Elevated B12 levels and mortality among inpatients at a university hospital in Colombia

Luisana Molina-Pimienta; Sandra Brigitte Amado-Garzón; Juan Camilo Salgado-Sánchez; Juan Manuel Vásquez-Jiménez

doi:10.15446/revfacmed.v71n4.105619

Elevated B12 levels and mortality among inpatients at a university hospital in Colombia

Título traducido de la contribución: Hipervitaminemia B12 y mortalidad en pacientes hospitalizados en un hospital universitario en Colombia

Luisana Molina-Pimienta, Sandra Brigitte Amado-Garzón, Juan Camilo Salgado-Sánchez, Juan Manuel Vásquez-Jiménez

Producción: Contribución a una revista › Artículo › revisión exhaustiva

Resumen

Introducción.

Se ha reportado una asociación entre los niveles altos de vitamina B12 y la ocurrencia de múltiples enfermedades.

Objetivo.

Describir las características clínicas de pacientes hospitalizados con hipervitaminemia B12, así como la tasa de mortalidad a 1 año.

Materiales y métodos.

Estudio observacional retrospectivo realizado en 93 pacientes con hipervitaminemia B12 atendidos en el Hospital Universitario San Ignacio de Bogotá (Colombia) entre 2013 y 2020. Los datos se describen utilizando medidas de tendencia central y de dispersión. Se realizaron análisis bivariados (prueba t de dos colas no pareada, prueba chi-cuadrado o prueba U de Mann-Whitney según el tipo de variable) para determinar diferencias entre los pacientes con niveles altos de B12 y aquellos con niveles muy altos.

Resultados.

La mediana de edad fue 68 años y el 62.36% de los pacientes eran hombres. El 61.29% de los participantes tenía dos o más comorbilidades asociadas con la hipervitaminemia B12. Además, en 86.02% el nivel de vitamina B12 no fue interpretado como anormal por el médico tratante. Se encontraron diferencias significativas en el antecedente de tabaquismo (p=0.043) y la presencia de lupus eritematoso sistémico (p=0.012) entre los pacientes con niveles altos de B12 y aquellos con niveles muy altos. Finalmente, la tasa de mortalidad a 1 año fue de 59.13%.

Conclusión.

La tasa de mortalidad a 1 año fue alta y un elevado porcentaje de pacientes tenía al menos dos comorbilidades asociadas a la hipervitaminemia B12. Además, en la mayoría de participantes, el médico tratante no interpretó correctamente el nivel elevado de esta vitamina.

Título traducido de la contribución	Hipervitaminemia B12 y mortalidad en pacientes hospitalizados en un hospital universitario en Colombia
Idioma original	Inglés
Número de artículo	e105619
Páginas (desde-hasta)	1-11
Número de páginas	11
Publicación	Revista de la Facultad de Medicina
Volumen	71
N.º	4
DOI	https://doi.org/10.15446/revfacmed.v71n4.105619 https://doi.org/10.15446/revfacmed.v71n4.105619
Estado	Publicada - 01 oct. 2023

Palabras clave

Vitamina B12
Neoplasia hematológica
Cáncer
Mortalidad

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

https://revistas.unal.edu.co/index.php/revfacmed/article/view/105619

Otros archivos y enlaces

Citar esto

@article{a68baf88d69c49119c20be1de89969db,

title = "Elevated B12 levels and mortality among inpatients at a university hospital in Colombia",

abstract = "Introduction: An association between high vitamin B12 levels and the occurrence of multiple diseases has been reported. Objective: To describe the clinical characteristics of inpatients with high levels of vitamin B12, as well as their 1-year mortality rate. Materials and methods: Retrospective observational study conducted in 93 patients with elevated B12 levels treated at the Hospital Universitario San Ignacio in Bogot{\'a} (Colombia) between 2013 and 2020. Data are described using measures of central tendency and dispersion. Bivariate analyses were performed (unpaired two-samples t-test, chi-square test or Mann-Whitney U test depending on the type of variable) to determine differences between patients with high B12 levels and those with very high levels. Results: Participant{\textquoteright}s median age was 68 years, 62.36% were male, and 61.29% had two or more comorbidities related to high B12 levels. In addition, in 86.02% of the patients, vitamin B12 level was not interpreted as abnormal by the treating physician. Significant differences were found between patients with high B12 levels and those with very high levels in terms of history of smoking (p=0.043) and the presence of systemic lupus erythematosus (p=0.012). Finally, the 1-year mortality rate was 59.13%. Conclusion: The 1-year mortality rate was high, and a high percentage of patients had at least two comorbidities that were associated with high B12 levels. Moreover, in most of the participants, the treating physician did not correctly interpret the elevated level of this vitamin.",

keywords = "Cancer, Hematologic Neoplasms, Mortality, Vitamin B12, Vitamina B12, Neoplasia hematol{\'o}gica, C{\'a}ncer, Mortalidad",

author = "Luisana Molina-Pimienta and Amado-Garz{\'o}n, {Sandra Brigitte} and Salgado-S{\'a}nchez, {Juan Camilo} and V{\'a}squez-Jim{\'e}nez, {Juan Manuel}",

note = "Publisher Copyright: {\textcopyright} 2023 Universidad Nacional de Colombia.",

year = "2023",

month = oct,

day = "1",

doi = "10.15446/revfacmed.v71n4.105619",

language = "English",

volume = "71",

pages = "1--11",

journal = "Revista de la Facultad de Medicina",

issn = "0120-0011",

publisher = "Universidad Nacional de Colombia",

number = "4",

}

TY - JOUR

T1 - Elevated B12 levels and mortality among inpatients at a university hospital in Colombia

AU - Molina-Pimienta, Luisana

AU - Amado-Garzón, Sandra Brigitte

AU - Salgado-Sánchez, Juan Camilo

AU - Vásquez-Jiménez, Juan Manuel

PY - 2023/10/1

Y1 - 2023/10/1

N2 - Introduction: An association between high vitamin B12 levels and the occurrence of multiple diseases has been reported. Objective: To describe the clinical characteristics of inpatients with high levels of vitamin B12, as well as their 1-year mortality rate. Materials and methods: Retrospective observational study conducted in 93 patients with elevated B12 levels treated at the Hospital Universitario San Ignacio in Bogotá (Colombia) between 2013 and 2020. Data are described using measures of central tendency and dispersion. Bivariate analyses were performed (unpaired two-samples t-test, chi-square test or Mann-Whitney U test depending on the type of variable) to determine differences between patients with high B12 levels and those with very high levels. Results: Participant’s median age was 68 years, 62.36% were male, and 61.29% had two or more comorbidities related to high B12 levels. In addition, in 86.02% of the patients, vitamin B12 level was not interpreted as abnormal by the treating physician. Significant differences were found between patients with high B12 levels and those with very high levels in terms of history of smoking (p=0.043) and the presence of systemic lupus erythematosus (p=0.012). Finally, the 1-year mortality rate was 59.13%. Conclusion: The 1-year mortality rate was high, and a high percentage of patients had at least two comorbidities that were associated with high B12 levels. Moreover, in most of the participants, the treating physician did not correctly interpret the elevated level of this vitamin.

AB - Introduction: An association between high vitamin B12 levels and the occurrence of multiple diseases has been reported. Objective: To describe the clinical characteristics of inpatients with high levels of vitamin B12, as well as their 1-year mortality rate. Materials and methods: Retrospective observational study conducted in 93 patients with elevated B12 levels treated at the Hospital Universitario San Ignacio in Bogotá (Colombia) between 2013 and 2020. Data are described using measures of central tendency and dispersion. Bivariate analyses were performed (unpaired two-samples t-test, chi-square test or Mann-Whitney U test depending on the type of variable) to determine differences between patients with high B12 levels and those with very high levels. Results: Participant’s median age was 68 years, 62.36% were male, and 61.29% had two or more comorbidities related to high B12 levels. In addition, in 86.02% of the patients, vitamin B12 level was not interpreted as abnormal by the treating physician. Significant differences were found between patients with high B12 levels and those with very high levels in terms of history of smoking (p=0.043) and the presence of systemic lupus erythematosus (p=0.012). Finally, the 1-year mortality rate was 59.13%. Conclusion: The 1-year mortality rate was high, and a high percentage of patients had at least two comorbidities that were associated with high B12 levels. Moreover, in most of the participants, the treating physician did not correctly interpret the elevated level of this vitamin.

KW - Cancer

KW - Hematologic Neoplasms

KW - Mortality

KW - Vitamin B12

KW - Vitamina B12

KW - Neoplasia hematológica

KW - Cáncer

KW - Mortalidad

UR - http://www.scopus.com/inward/record.url?scp=85200683605&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/1135e2fb-9a57-30d1-bc6a-ae0aa80a8f85/

U2 - 10.15446/revfacmed.v71n4.105619

DO - 10.15446/revfacmed.v71n4.105619

M3 - Article

SN - 0120-0011

VL - 71

SP - 1

EP - 11

JO - Revista de la Facultad de Medicina

JF - Revista de la Facultad de Medicina

IS - 4

M1 - e105619

ER -

Elevated B12 levels and mortality among inpatients at a university hospital in Colombia

Resumen

Palabras clave

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto